ArticleHeliyon2024
Generalization of Odd Ramos-Louzada generated family of distributions: Properties, characterizations, and applications to diabetes and cancer survival datasets.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Complementary Asymmetric-Odds Weibull Distribution: A Flexible Lifetime Model with Applications to Hazard Rate Modeling and Change-Point Analysis.Entropy (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Probability distributions offer the best description of survival data and as a result, various lifetime models have been proposed. However, some of these survival datasets are not followed or sufficiently fitted by the existing proposed probability distributions. This paper presents a novel Kumaraswamy Odd Ramos-Louzada-G (KumORL-G) family of distributions together with its statistical features, including the quantile function, moments, probability-weighted moments, order statistics, and entropy measures. Some relevant characterizations were obtained using the hazard rate function and the ratio of two truncated moments. In light of the proposed KumORL-G family, a five-parameter sub-model, the Kumaraswamy Odd Ramos-Louzada Burr XII (KumORLBXII) distribution was introduced and its parameters were determined with the maximum likelihood estimation (MLE) technique. Monte Carlo simulation was performed and the numerical results were used to evaluate the MLE technique. The proposed probability distribution's significance and applicability were empirically demonstrated using various complete and censored datasets on the survival times of cancer and diabetes patients. The analytical results showed that the KumORLBXII distribution performed well in practice in comparison to its sub-models and several other competing distributions. The new KumORL-G for diabetes and cancer survival data is found extremely efficient and offers an enhanced and novel technique for modeling survival datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.